Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Marc Feldmann currently holds 250,874 shares of 180 Life Sciences Corp. (ATNF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Feldmann has been a net buyer of ATNF stock. They have purchased $203.5K and sold $4.8K worth of shares.
Marc Feldmann's most recent insider trade was on Dec 28, 2023, when they sold 135,377 shares at $0.00 per share.
Marc Feldmann serves as Executive at 180 Life Sciences Corp. (ATNF). They have executed 6 insider transactions totaling $208.3K over their tenure at the company.
Marc Feldmann holds the position of Executive at 180 Life Sciences Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Marc Feldmann has shown a buying trading pattern, with $203.5K in total purchases and $4.8K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Marc Feldmann was on Sep 30, 2021, when they purchased $819.8K worth of ATNF shares. This transaction involved 136,636 shares at $6.00 per share.
Marc Feldmann currently owns 250,874 shares of 180 Life Sciences Corp. (ATNF), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Marc Feldmann's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Marc Feldmann has 6 Form 4 filings on record as an insider at 180 Life Sciences Corp..
Set alerts for Marc Feldmann and 40,000+ other insiders.